Posts Tagged ‘bud’

10 People Who Got Stoned Who Probably Shouldn’t Have



As everyone who reads this site regularly knows, I am a major advocate of smoking marijuana in large quantities. Moreso than that though, I think everyone should smoke responsibly. Although I love getting stoned and being around other stoners, there are certain people who probably shouldn’t be getting high. You don’t want your surgeon to show up to surgery stoned. You don’t want your pilot to be stoned. Everyone else is ok though, unless you are one of the people on this list who got stoned but probably shouldn’t have.


Note: I’m not 100% sure all of these videos or all of these people are actually stoned.  You guys watch and give me your opinion.  I am pretty sure all of them are at least a little buzzed.

This is the funniest police officer EVER!

That would be the best day of a young firefighter’s life

Stoned reporting about weed, how ironic.

This teacher is stoned out of his mind. I mean come on, Boston? A great city? Just kidding Bostonians, we love you.

Don’t get stoned on Judge Judy, she doesn’t like people laughing on her show.

How stupid can you be to admit to cops that you’re stoned? I mean, really?

Stoned Granny almost didn’t make this list because she should have the right to get stoned, but the guy with her is an idiot.

This mom probably got stoned and forgot where she left her weed. This is a bad way to remember.

Another guy that got stoned before Judge Judy. This guy looks like he had better shit than the first guy.

Youtube says this German weather lady is stoned… We’re going to have to agree.


U.S. Denies Prince of Pot, Marc Emery, a Transfer to Canadian Prison

VANCOUVER — Canada’s so-called “Prince of Pot” has been told he won’t be allowed a prison transfer and must serve his entire sentence in the United States.

Kirk Tousaw, a Canadian lawyer for Vancouver resident Marc Emery, said American authorities told his client in a letter received Friday that the U.S. government refused his transfer on April 6 due to the “seriousness of the offence” and “law enforcement concerns.”

He received the news in a federal holding institution in Oklahoma awaiting transfer to a prison in Mississippi.

Emery, who had been imprisoned in Georgia, pleaded guilty May 24 2010 in Seattle to selling marijuana seeds to Americans through his Vancouver-based catalogue company and was sentenced to five years in prison.

Tousaw said he can re-apply for transfer to a Canadian institution again for two years.

Emery’s wife Jodie was disheartened.

“There’s nothing we can do at this point beyond asking for a presidential pardon in the U.S., which I’m going to start campaigning for, actually, because I have to do whatever I can to get Marc home,” she said Friday. “We’re both devastated to hear this news. The idea of him spending the next three or four years in the U.S. federal prison system for political activism financed by seed sales — sales that now happen legally across America every day — is sickening and heartbreaking,”she adde.

“I’m still in shock. I’m asking everyone who has ever felt Marc’s treatment was unjust to get out and vote against the Conservatives on May 2 to punish them for extraditing Marc in the first place, one year ago on May 10.”

Tousaw said that with good behaviour, it’s possible Emery could get out after serving 85% of his sentence.

“This refusal is a terrible affront to the sovereignty of Canada,” he said. “Marc is a target of political persecution that appears to have transcended his conviction and now infects the treaty transfer process. He qualifies under every relevant factor and should have been allowed to serve out his jail term in Canada, close to his wife Jodie and in the country in which all of his activity took place. We call upon Prime Minister (Stephen) Harper and the leaders of the Liberal Party and NDP to stand up for this

Emery’s announcement comes the same week an Ontario Superior Court judge ruled that two key parts of the Controlled Drugs and Substances Act are unconstitutional and gave the federal government three months to respond to the decision.

If the government does not respond with a successful delay or re-regulation of marijuana, the drug will be legal to possess and produce in Ontario, where the decision is binding.

Marinol vs. Natural Cannabis, which is right for you?


Marinol1 (dronabinol) is the only US FDA-approved synthetic cannabinoid. It is often marketed as a legal pharmaceutical alternative to natural cannabis.

Marinol is manufactured as a gelatin capsule containing synthetic delta-9-tetrahydrocannabinol (THC) in sesame oil. It is taken orally and is available in 2.5mg, 5mg and/or 10mg dosages. Marinol may be prescribed for the treatment of cachexia (weight loss) in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.

Despite FDA approval2, Marinol typically provides only limited relief to select patients, particularly when compared to natural cannabis and its cannabinoids. Marinol should remain a legal option for patients and physicians; however, federal and state laws should be amended to allow for those patients who are unresponsive to synthetic THC the ability to use natural cannabis and its cannabinoids as a medical therapy without fear of arrest and/or criminal prosecution. By prohibiting the possession and use of natural cannabis and its cannabinoids, patients are unnecessarily restricted to use a synthetic substitute that lacks much of the therapeutic efficacy of natural cannabis.

I. Marinol Lacks Several of the Therapeutic Compounds Available in Natural Cannabis

Chemical compounds in cannabis, known as cannabinoids, are responsible for its numerous therapeutic benefits. Scientists have identified 66 naturally occurring cannabinoids.3

The active ingredient in Marinol, synthetic delta-9-tetrahyrdocannabinol (THC), is an analogue of one such compound, THC. However, several other cannabinoids available in cannabis — in addition to naturally occurring terpenoids (oils) and flavonoids (phenols) — have also been clinically demonstrated to possess therapeutic utility. Many patients favor natural cannabis to Marinol because it includes these other therapeutically active cannabinoids.

For example, cannabidol (CBD) is a non-psychoactive cannabinoid that has been clinically demonstrated to have analgesic, antispasmodic, anxiolytic, antipsychotic, antinausea, and anti-rheumatoid arthritic properties.4

Animal and human studies have shown CBD to possess anti-convulsant properties, particularly in the treatment of epilepsy.5 Natural extracts of CBD, when administered in combination with THC, significantly reduce pain, spasticity and other symptoms in multiple sclerosis (MS) patients unresponsive to standard treatment medications.6

Clinical studies also demonstrate CBD to be neuroprotective against glutamate neurotoxicity7 (i.e. stroke), cerebral infarction8 (localized cell death in the brain), and ethanol-induced neurotoxicity,9 with CBD being more protective against glutamate neurotoxicity than either ascorbate (vitamin C) or alpha-tocopherol (vitamin E).10 Clinical trials have also shown CBD to possess anti-tumoral properties,11 inhibiting the growth of glioma (brain tumor) cells in a dose dependent manner and selectively inducing apoptosis (programmed cell death) in malignant cells.12

Additional cannabinoids possessing clinically demonstrated therapeutic properties include: cannabinol (anticonvulsant13 and anti-inflammatory14 activity); cannabichromine (anti-inflammatory15 and antidepressant16 activity); and cannabigerol (anti-tumoral17 and analgesic18 activity). Natural cannabis’ essential oil components (terpenoids) exhibit anti-inflammatory properties19 and its flavonoids possess antioxidant activity.20 Emerging clinical evidence indicates that cannabinoids may slow disease progression21 in certain autoimmune and neurologic diseases, including multiple sclerosis22 (MS), Amyotrophic Lateral Sclerosis23 (Lou Gehrig’s disease) and Huntington’s Disease.24

Clinical data indicate that the synergism of these compounds is likely more efficacious25 than the administration of synthetic THC alone.26 For example, McPartland and Russo write: “Good evidence shows that secondary compounds in cannabis may enhance beneficial effects of THC. Other cannabinoid and non-cannabinoid compounds in herbal cannabis … may reduce THC-induced anxiety, cholinergic deficits, and immunosuppression. Cannabis terpenoids and flavonoids may also increase cerebral blood flow, enhance cortical activity, kill respiratory pathogens, and provide anti-inflammatory activity.”27 In an in vitro model of epilepsy, natural cannabis extracts performed better than THC alone.28 In human trials, patients suffering from multiple sclerosis experienced greater symptomatic relief from sublingual natural cannabis extracts than from the administration of oral THC.29 In 2005, Health Canada approved the oral spray Sativex30 — which contains precise ratios of the natural cannabinoid extracts THC and CBD, among other compounds — for prescription use for MS-related symptoms.31

II. Marinol is More Psychoactive Than Natural Cannabis

Patients prescribed Marinol frequently report that its psychoactive effects are far greater than those of natural cannabis. Marinol’s adverse effects include: feeling “high,” drowsiness, dizziness, confusion, anxiety, changes in mood, muddled thinking, perceptual difficulties, coordination impairment, irritability, and depression.32 These psychoactive effects may last four to six hours.33 About one-third of patients prescribed Marinol report experiencing one or some of these adverse effects.34

Marinol’s oral route of administration is responsible, in part, for its heightened psychoactivity compared to inhaled cannabis. Once swallowed, Marinol passes from the stomach to the small intestine before being absorbed into the bloodstream. Following absorption, Marinol passes through the liver where a significant proportion of the drug is metabolized into other chemicals.35 One of these chemicals, 11-hydroxy-THC, may be four to five times more potent than natural THC,36 and is produced in greater quantities.37 Thus, patients administered Marinol experience the psychoactive effects of both THC and 11-hydroxy-THC, greatly increasing the likelihood that they will suffer from an adverse psychological reaction. By comparison, only minute quantities of 11-hydroxy-THC are produced when cannabis is inhaled.38 Moreover, Marinol lacks the compound cannabidiol, which possesses anxiolytic activity and likely modifies and/or diminishes much of THC’s psychoactivity in natural cannabis.39

To keep reading click on link for PART 2


%d bloggers like this: